Hyperactive Delirium Requires More Aggressive Management in Patients With COVID-19: Temporarily Rethinking "Low and Slow"

J Pain Symptom Manage. 2020 Aug;60(2):e31-e32. doi: 10.1016/j.jpainsymman.2020.05.013. Epub 2020 May 21.

Authors

Barton J Sanders¹, Melissa Bakar², Sonal Mehta², M Carrington Reid², Eugenia L Siegler², Robert C Abrams², Ronald D Adelman², Mark S Lachs²

Affiliations

¹ Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York, New York, USA. Electronic address: bas9072@med.cornell.edu.
² Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York, New York, USA.

No abstract available

Publication types

Letter

MeSH terms

Antipsychotic Agents / administration & dosage
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / therapy*
Delirium / complications*
Delirium / therapy*
Disease Management
Hospice Care
Humans
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / therapy*
Psychomotor Agitation / complications*
Psychomotor Agitation / therapy*
Safety

Substances

Antipsychotic Agents

Grants and funding